Rajbala Pharmaceutical And Surgicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 3.00 M
About Rajbala Pharmaceutical And Surgicals
Rajbala Pharmaceutical And Surgicals Private Limited (RPASPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 April 2020 (Four years and nine months 17 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 M.
Rajeev Kumar and Garima Jaswal serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230DL2020PTC363377
-
Company No.
363377
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Apr 2020
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Rajbala Pharmaceutical And Surgicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Kumar
|
Director | 22-Apr-2020 | Current |
|
Garima Jaswal
|
Director | 22-Apr-2020 | Current |
Financial Performance of Rajbala Pharmaceutical And Surgicals.
Rajbala Pharmaceutical And Surgicals Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rajbala Pharmaceutical And Surgicals?
In 2021, Rajbala Pharmaceutical And Surgicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Grh Enterprises Private LimitedRajeev Kumar and Garima Jaswal are mutual person
-
Ayrus Sri Health Care Solutions Private LimitedRajeev Kumar is a mutual person
-
Rajvans Pharmaceutical And Surgicals Private Limited
Rajeev Kumar and Garima Jaswal are mutual person
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jul 2022 | State Bank Of India | ₹3.00 M | Open |
How Many Employees Work at Rajbala Pharmaceutical And Surgicals?
Unlock and access historical data on people associated with Rajbala Pharmaceutical And Surgicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rajbala Pharmaceutical And Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rajbala Pharmaceutical And Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.